NITROSAMINES: Where now?
Here, Dave Elder reflects on the three main instances of nitrosamine contamination as impurities in drug products.
United Kingdom Dave Elder Kenyonm Kalgutkar Stakeholder Forum Nonclinical Evaluation For Anticancer Pharmaceuticals British Pharmacopoeia Expert Advisory Group
Source: europeanpharmaceuticalreview.com